ERN1 and neoplasm: For instance, DCs infiltrating ovarian cancer [typified by expression of the cDC2/MdC marker CD11b+ (29)] display persistent IRE1/XBP1s activation which blunts their immunostimulatory functions driving tumor progression (26).